EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1) |
Registration Statement (Form S-3 No. 333-291489) and related Prospectus of Registrant, |
|
2) |
Registration Statement (Form S-8 No. 333-265540) pertaining to the 2018 Omnibus Incentive Plan of Registrant, |
|
3) |
Registration Statement (Form S-8 No. 333-168390) pertaining to the 2000 Employee Stock Purchase Plan of Registrant, |
|
4) |
Registration Statement (Form S-8 No. 333-225708) pertaining to the 2018 Omnibus Incentive Plan of Registrant, |
|
5) |
Registration Statement (Form S-8 No. 333-147336) pertaining to the 2000 Employee Stock Purchase Plan of Registrant, and |
|
6) |
Registration Statement (Form S-8 No. 333-152676) pertaining to the 2008 Equity Incentive Plan of Registrant; |
of our report dated March 12, 2026, with respect to the consolidated financial statements of Filana Therapeutics, Inc. (formerly known as “Cassava Sciences, Inc.”) included in this Annual Report (Form 10-K) of Filana Therapeutics, Inc. for the year ended December 31, 2025.
/s/ Ernst &Young LLP
Austin, Texas
March 12, 2026